AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
On July 30, 2025,
(AZN) rose 3.53% with a trading volume of $0.78 billion, a 26.72% decline from the previous day’s volume. The stock ranked 143rd in trading activity among listed equities.Technical analysis from LKP Securities highlighted AstraZeneca Pharma India as a buy, with a price target of Rs 9,850 and a stop-loss at Rs 9,050. The stock broke out of a consolidation phase, trading above the 50-day exponential moving average and showing a bullish RSI crossover. Analysts noted sustained momentum as long as the stock holds above Rs 9,050, with near-term upside potential toward Rs 9,850.
A strategy of purchasing the top 500 stocks by daily trading volume and holding them for one day generated a 166.71% return from 2022 to the present, significantly outperforming the benchmark’s 29.18% return. This highlights the strategy’s strong profitability over the period, driven by liquidity and investor interest in high-volume equities.

Market Watch column provides a thorough analysis of stock market fluctuations and expert ratings.

Dec.17 2025

Dec.17 2025

Dec.17 2025

Dec.16 2025

Dec.16 2025
Daily stocks & crypto headlines, free to your inbox
How can investors navigate the current market volatility?
What sectors are most affected by the tech rout?
What are the implications of the S&P 500's weakness for Bitcoin and altcoin volatility?
How can investors adjust their portfolios in response to the current market conditions?
Comments
No comments yet